UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation
Year: 2018
Type: article
Study design: Observational Study
Abstract: Background: Linaclotide, a guanylate cyclase C agonist, has been shown in clinical trials to improve symptoms of irritable bowel syndrome with constipation (IBS-C). Here we report data from a real-world study of linaclotide in the UK. Methods: This 1-year, multicentre, prospective, observational study in the UK enrolled patients aged 18 years and over initiating linaclotide for IBS-C. The primary assessment was change from baseline in IBS Symptom Severity Scale (IBS-SSS) score at 12 weeks, assessed in patients with paired baseline and 12-week data. Change from baseline in IBS-SSS score at 52 weeks was a secondary assessment. Adverse events were recorded. Results: In total, 202 patients were enrolled: 185 (91.6%) were female, median age was 44.9 years (range 18.1–77.2) and 84 (41.6%) reported baseline laxative use. Mean (standard deviation) baseline IBS-SSS score was 339 (92), with most patients ( n = 129; 66.8%) classified as having severe disease (score ⩾300). In patients with paired data, there was a significant mean (95% confidence interval) decrease in IBS-SSS score from baseline to 12 weeks [−77.0 (−96.3, −57.7); p < 0.001; n = 124] and baseline to 52 weeks [−70.7 (−95.0, −46.5); p < 0.001; n = 76]. Overall, 174 adverse events were reported in 77 (38.1%) patients, most commonly diarrhoea ( n = 54; 26.7%), abdominal pain ( n = 21; 10.4%) and abdominal distension ( n = 13; 6.4%). Conclusion: Linaclotide significantly improved IBS-SSS score at 12 and 52 weeks. These results provide insights into outcomes with linaclotide treatment over 1 year in patients with IBS-C in real-world clinical practice.
Institutions: County Durham and Darlington NHS Foundation Trust, University Hospital of North Durham, Doncaster Royal Infirmary, South Eastern Health and Social Care Trust, London North West Healthcare NHS Trust, St Mark's Hospital, Imperial College London, Sheffield Teaching Hospitals NHS Foundation Trust, NHS Lothian, Western General Hospital, University Hospitals of North Midlands NHS Trust, Keele University, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, University of Manchester, Allergan (United Kingdom), University College Hospital, University College London Hospitals NHS Foundation Trust
Language: English
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,700
Funder: Allergan
OpenAlex ID: W2894886573
